Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | GILD | REGN | BIIB |
| Company | Vertex Pharmaceutic | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 402.44 | 273.45 | 67.47 | 911.09 | 201.21 |
| High | 403.88 | 274.35 | 67.90 | 915.00 | 205.36 |
| Low | 393.00 | 267.24 | 65.32 | 876.75 | 198.11 |
| Last | 398.18 | 268.40 | 65.57 | 892.42 | 199.70 |
| Change | -2.58 | -4.61 | -1.51 | -14.12 | -2.29 |
| % Change | -0.64% | -1.69% | -2.25% | -1.56% | -1.13% |
| Volume | 276,043 | 543,248 | 4,118,045 | 233,464 | 650,081 |
| 20-Day Average Volume | 937,268 | 2,084,862 | 6,295,121 | 436,266 | 1,231,303 |
| Previous Close | 400.76 | 273.01 | 67.08 | 906.54 | 201.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 402.14 | 270.63 | 68.71 | 922.25 | 201.33 |
| 20-Day Raw Stochastic | 10.86% | 26.21% | 4.33% | 9.28% | 36.47% |
| 20-Day Relative Strength | 40.55% | 43.63% | 29.30% | 33.70% | 40.89% |
| Weighted Alpha | +13.52 | +8.34 | -23.05 | +10.22 | -35.70 |
| Today's Opinion | 8% Buy | 72% Sell | 100% Sell | 8% Sell | 100% Sell |
| Previous Opinion | 8% Buy | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 56% Buy | 24% Buy | 88% Sell | 80% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 04/18/24 | +1.99% since 04/18/24 | -0.71% since 04/18/24 | -0.95% since 04/18/24 | +4.82% since 04/18/24 |
| Low | 391.25 on 04/19/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 876.75 on 04/25/24 | 189.44 on 04/19/24 |
| High | 406.86 on 04/23/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 920.73 on 04/19/24 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | -5.22% since 03/25/24 | -4.57% since 03/25/24 | -9.49% since 03/25/24 | -7.87% since 03/25/24 | -7.84% since 03/25/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 876.75 on 04/25/24 | 189.44 on 04/19/24 |
| High | 421.45 on 04/01/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -8.29% since 01/25/24 | -13.62% since 01/25/24 | -18.12% since 01/25/24 | -6.68% since 01/25/24 | -18.89% since 01/25/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 876.75 on 04/25/24 | 189.44 on 04/19/24 |
| High | 448.40 on 01/30/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 998.33 on 02/28/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | +8.62% since 10/25/23 | -1.53% since 10/25/23 | -16.20% since 10/25/23 | +11.10% since 10/25/23 | -19.06% since 10/25/23 |
| Low | 341.90 on 11/16/23 | 249.70 on 10/31/23 | 65.32 on 04/25/24 | 769.19 on 10/27/23 | 189.44 on 04/19/24 |
| High | 448.40 on 01/30/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 103,580,040 | 146,436,016 | 83,519,768 | 99,503,640 | 29,361,468 |
| Shares Outstanding, K | 258,459 | 536,376 | 1,245,077 | 109,762 | 145,361 |
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 | 9,835,600,000 |
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 | 1,161,100,000 |
| Last Quarter Sales | 2,517,700,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 | 2,386,300,000 |
| Last Quarter Net Income | 968,800,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 | 249,700,000 |
| 60-Month Beta | 0.35 | 0.58 | 0.19 | 0.11 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 4.20 on 02/05/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/06/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 30.13 | 14.67 | 9.97 | 24.14 | 13.11 |